Stock listing
NYSE American:APUS Apimeds Pharmaceuticals US, Inc. Stock
Home listing (NYSE American) of Apimeds Pharmaceuticals US, Inc.
Follow Apimeds Pharmaceuticals US, Inc. into a list and get an email when it puts out news.
Share price · AMEX:APUS
$2.89 USD -0.12 (-4.0%)
Close on Nov 2, 2026
- Day range
- $2.78 – $3.02 USDNov 2, 2026
- Volume
- 38,230 sharesNov 2, 2026
- Market cap
- $4.36M USDAt the close on Nov 2, 2026 · price × 1.51M shares outstanding
- 52-week range
- $1.51 – $59.70 USDLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
- Traded on an average day
- $21.44M USDMedian day 66,000 shares · last 3 months, Aug 3, 2026 – Nov 2, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE American:APUS · Home | $2.89 USD | -0.12 (-4.0%) | 38,230 | $3.01 | $3.02 | $2.78 | $3.01 | Close on Nov 2, 2026 |
Daily closes
Last 3 months, Aug 3, 2026 – Nov 2, 2026 · AMEX:APUS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $2.89 | -0.12 | -4.0% | $3.01 | $3.02 | $2.78 | 38,230 | |
| $3.01 | -0.20 | -6.2% | $3.11 | $3.11 | $2.84 | 20,052 | |
| $3.21 | +0.14 | +4.6% | $2.89 | $3.21 | $2.83 | 48,752 | |
| $3.07 | +0.02 | +0.7% | $2.39 | $3.095 | $2.39 | 68,288 | |
| $3.05 | +0.155 | +5.4% | $2.90 | $3.05 | $2.65 | 143,086 | |
| $2.895 | +0.005 | +0.2% | $2.92 | $3.06 | $2.713 | 29,730 | |
| $2.89 | -0.27 | -8.5% | $3.07 | $3.175 | $2.81 | 35,400 | |
| $3.16 | -0.09 | -2.8% | $3.14 | $3.25 | $3.06 | 42,300 | |
| $3.25 | -0.16 | -4.7% | $3.51 | $3.57 | $3.005 | 128,000 | |
| $3.41 | -0.09 | -2.6% | $3.43 | $3.55 | $3.21 | 66,000 | |
| $3.50 | -0.54 | -13.4% | $3.92 | $3.95 | $3.40 | 101,700 | |
| $4.04 | -0.35 | -8.0% | $4.16 | $4.35 | $3.90 | 43,200 | |
| $4.39 | -0.19 | -4.1% | $4.25 | $4.415 | $4.00 | 109,000 | |
| $4.58 | -0.04 | -0.9% | $4.60 | $4.81 | $4.25 | 235,300 | |
| $4.62 | -0.58 | -11.2% | $4.87 | $4.91 | $4.26 | 339,800 | |
| $5.20 | +0.18 | +3.6% | $5.43 | $6.036 | $4.971 | 1,394,300 | |
| $5.02 | -0.49 | -8.9% | $5.54 | $5.72 | $4.40 | 3,346,300 | |
| $5.51 | -1.54 | -21.8% | $6.43 | $6.496 | $5.21 | 1,112,800 | |
| $7.05 | -0.08 | -1.1% | $8.00 | $9.84 | $6.86 | 22,395,400 | |
| $7.13 | +2.54 | +55.3% | $4.91 | $8.39 | $4.71 | 43,838,600 | |
| $4.59 | +1.37 | +42.5% | $4.99 | $5.83 | $4.21 | 33,787,400 | |
| $3.22 | -0.88 | -21.5% | $4.10 | $4.16 | $3.10 | 138,400 | |
| $4.10 | -0.90 | -18.0% | $4.90 | $5.09 | $4.10 | 145,800 | |
| $5.00 | -0.02 | -0.4% | $5.04 | $5.25 | $4.72 | 190,100 | |
| $5.02 | -1.37 | -21.4% | $6.17 | $6.17 | $4.63 | 762,100 | |
| $6.39 | -0.86 | -11.9% | $6.33 | $6.50 | $5.56 | 858,800 | |
| $7.25 | +2.33 | +47.4% | $8.32 | $9.14 | $5.39 | 37,114,300 | |
| $4.92 | +2.63 | +114.8% | $6.99 | $8.74 | $4.61 | 87,850,200 | |
| $2.29 | +0.44 | +23.8% | $1.81 | $2.30 | $1.745 | 152,500 | |
| $1.85 | +0.18 | +10.8% | $1.65 | $1.999 | $1.613 | 132,400 | |
| $1.67 | -0.10 | -5.6% | $1.72 | $1.865 | $1.67 | 671,000 | |
| $1.77 | +0.10 | +6.0% | $1.68 | $2.10 | $1.63 | 1,335,500 | |
| $1.67 | +0.07 | +4.4% | $1.73 | $1.92 | $1.60 | 83,900 | |
| $1.60 | -0.04 | -2.4% | $1.71 | $1.71 | $1.51 | 64,300 | |
| $1.64 | -0.45 | -21.5% | $2.11 | $2.11 | $1.60 | 66,200 | |
| $2.09 | -0.015 | -0.7% | $2.39 | $2.39 | $2.025 | 29,800 | |
| $2.105 | -0.065 | -3.0% | $2.16 | $2.26 | $2.09 | 20,700 | |
| $2.17 | -0.12 | -5.2% | $2.26 | $2.47 | $2.12 | 40,600 | |
| $2.29 | -0.01 | -0.4% | $2.30 | $2.35 | $2.17 | 29,500 | |
| $2.30 | -0.12 | -5.0% | $2.40 | $2.405 | $2.25 | 17,421 | |
| $2.42 | -0.09 | -3.6% | $2.49 | $2.60 | $2.42 | 24,400 | |
| $2.51 | -0.12 | -4.6% | $2.66 | $2.71 | $2.40 | 50,600 | |
| $2.63 | -0.91 | -25.7% | $3.17 | $3.38 | $2.51 | 84,100 | |
| $3.54 | -0.34 | -8.8% | $3.87 | $3.87 | $3.41 | 29,200 | |
| $3.88 | +0.01 | +0.3% | $4.09 | $4.09 | $3.73 | 8,200 | |
| $3.87 | -0.08 | -2.0% | $4.10 | $4.10 | $3.861 | 9,100 | |
| $3.95 | -0.65 | -14.1% | $4.63 | $4.81 | $3.737 | 172,200 | |
| $4.60 | -0.37 | -7.4% | $4.74 | $4.99 | $4.358 | 230,135 | |
| $4.97 | +0.22 | +4.6% | $4.78 | $5.35 | $4.65 | 49,100 | |
| $4.75 | -0.09 | -1.9% | $4.34 | $4.75 | $4.34 | 15,900 | |
| $4.84 | +0.45 | +10.3% | $4.30 | $5.43 | $4.175 | 559,500 | |
| $4.39 | 0.00 | 0.0% | $4.23 | $4.50 | $4.091 | 17,200 | |
| $4.39 | +0.39 | +9.7% | $3.88 | $4.55 | $3.69 | 23,000 | |
| $4.00 | -0.28 | -6.5% | $3.99 | $4.30 | $3.85 | 38,200 | |
| $4.28 | -0.27 | -5.9% | $3.45 | $4.30 | $3.39 | 1,617,000 | |
| $4.55 | -0.15 | -3.2% | $4.72 | $4.93 | $4.55 | 21,300 | |
| $4.70 | +0.04 | +0.9% | $4.37 | $4.99 | $4.37 | 52,400 | |
| $4.66 | +0.03 | +0.6% | $4.46 | $4.73 | $4.36 | 311,300 | |
| $4.63 | +0.39 | +9.2% | $4.47 | $4.63 | $4.285 | 6,100 | |
| $4.24 | +0.01 | +0.2% | $4.39 | $4.61 | $4.23 | 7,700 | |
| $4.23 | -0.60 | -12.4% | $4.75 | $4.815 | $4.23 | 8,300 | |
| $4.83 | +0.18 | +3.9% | $4.69 | $4.89 | $4.547 | 6,800 | |
| $4.65 | -0.27 | -5.5% | $4.77 | $5.155 | $4.65 | 16,900 | |
| $4.92 | +0.07 | +1.4% | $4.90 | $5.43 | $4.659 | 18,600 | |
| $4.85 | -0.30 | -5.8% | $5.18 | $5.30 | $4.83 | 23,600 |
- Ticker
- NYSE American:APUS
- Asset type
- Stock
- Exchange
- NYSE American
- Currency
- USD
What changed lately
Latest news
D. Boral Capital Acted as Sole Bookrunner to Apimeds Pharmaceuticals US, Inc. (NYSE: APUS) in connection with its $13.5 Million Initial Public Offering
Sep 14, 2026
Closed $2.09 (-0.7%) on Sep 14, 2026
MindWave Innovations Inc., a Wholly Owned Subsidiary of Apimeds Pharmaceuticals US, Inc., Announces MindChain: World's First Fully Insured Blockchain, Launching in October
Jul 28, 2026
Closed $8.00 (+27.2%) on Jul 28, 2026
Apimeds Pharmaceuticals US Settles with Inscobee; Merger Proceeds, $100 Million PIPE Financing to Close, and Lōkahi Therapeutics to Advance Apitox Program
May 5, 2026
Closed $30.00 (+59.6%) on May 5, 2026
Annual Report for Fiscal Year Ending December 31, 2025 (Form 10-K)
May 4, 2026
Closed $18.80 (0.0%) on May 4, 2026
Inscobee Inc. and Apimeds, Inc. Reaffirms Appointment of New Board of Directors for Apimeds Pharmaceuticals US, Inc.
Mar 25, 2026
Closed $17.50 (+2.3%) on Mar 25, 2026
Apimeds Pharmaceuticals US Inc. Announces Material Breach of Merger Agreement by Inscobee Inc. (KS: 006490) and Apimeds Inc.; Prepares Filing Emergency Action in Delaware Court of Chancery
Mar 24, 2026
Closed $17.10 (-12.3%) on Mar 24, 2026
Apimeds Pharmaceuticals and Lokahi Therapeutics Announce FDA Type C Meeting Scheduled for LT-100
Feb 12, 2026
Closed $11.00 (-24.1%) on Feb 12, 2026
Apimeds Pharmaceuticals and Lōkahi Therapeutics Announce FDA Type C Meeting Scheduled for LT‑100 (Apitox)
Feb 11, 2026
Closed $11.00 (-24.1%) on Feb 12, 2026
Apimeds Pharmaceuticals and MindWave Innovations Announce Closing of $100MM PIPE Financing and Activation of 1,000 Bitcoin to Power AI-Driven Yield Generation Strategy
Dec 10, 2025
Closed $21.00 (-1.4%) on Dec 10, 2025
Apimeds and MindWave Announce Merger, Integrating Biotech Growth with AI-Driven Digital Treasury Yield Generation Backed by $100M PIPE
Dec 1, 2025
Closed $22.90 (-21.0%) on Dec 1, 2025
Decks
Investor Presentation (July 2025)
Investor deck · 24 slides · July 2025
IPO Roadshow (February 2025)
IPO roadshow · 30 slides · Feb 10, 2025
Apimeds Pharmaceuticals US, Inc. on 6ix
- News releases
- 11 in the last 12 months · 19 in all · newest Sep 14, 2026 · oldest 2025
- Decks
- 2 decks · latest July 2025
Where Apimeds Pharmaceuticals US, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE American:APUS · Home listing · This page | NYSE American | United States | USD |
| BOATS:APUS | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Apimeds Pharmaceuticals US, Inc.